7.84
price up icon2.75%   0.21
 
loading

Novavax Inc Stock (NVAX) Forecast

The Novavax Inc (NVAX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $140.60, representing a +1,693% increase from the current price of $7.84. The highest analyst price target is $187.67, and the lowest is $93.52.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month NVAX Price Target
Average 202.45 (+2,482% Upside)
loading

Is Novavax Inc (NVAX) A Buy Now?

Oscillators
Name Value Action
RSI(14) 60.14 Neutral
STOCH(9,6) 74.89 Neutral
STOCHRSI(14) 60.00 Neutral
MACD(12,26) 0.6338 Buy
ADX(14) 32.89 Buy
William %R -40.55 Neutral
CCI(14) 34.00 Neutral
Buy: 2 Sell: 0 Neutral: 5
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
8.9657
Sell
8.8627
Buy
MA20
8.0089
Buy
8.3115
Buy
MA50
7.3015
Buy
7.6358
Buy
MA100
6.9595
Buy
7.4919
Buy
MA200
7.7013
Buy
8.142
Buy
Buy: 9 Sell: 1 Neutral: 0
Summary: Buy
According to our latest analysis, NVAX could be considered a Strong Buy, with 17 technical analysis indicators signaling 11 Buy signals, 1 signaling Sell signals and 5 Neutral signals. This might be a good time to open fresh positions on NVAX, as trading bullish markets is always a lot easier
  1. RSI (Relative Strength Index): The RSI(14) value of 60.14 indicates that NVAX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 74.89 indicates that NVAX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 60 indicates that NVAX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 32.89 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 34 indicates that NVAX is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term NVAX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Novavax Inc financial reports and earnings history, Novavax Inc (NVAX) stock could reach $4.1836 by 2030, $5.3488 by 2040 and $83.18 by 2050. See the projected annual prices until 2050 of the Novavax Inc stock below:

  • Novavax Inc (NVAX) is expected to reach an average price of $2.8087 in 2035, with a high prediction of $4.7215 and a low estimate of $2.5387. This indicates an $-64.17% rise from the last recorded price of $7.84.
  • Novavax Inc (NVAX) stock is projected to chart a bullish course in 2040, with an average price target of $3.3442, representing an $-57.34% surge from its current level. The forecast ranges from a conservative $2.508 to a sky-high $5.3488.
  • Our analysts predict Novavax Inc (NVAX) to jump 31.31% by 2045, soaring from $10.22 to an average price of $10.29, potentially reaching $27.34. While $10.22 is the low estimate, the potential upside is significant.
  • Novavax Inc (NVAX) stock is expected to climb by 2050, reaching an average of $74.50, a $850.20% jump from its current level. However, a wide range of estimates exists, with high and low targets of $83.18 and $58.01, respectively, highlighting the market's uncertainty.

Novavax Inc Stock (NVAX) Year by Year Forecast

Novavax Inc Stock (NVAX) Price Forecast for 2025

Novavax Inc Stock (NVAX) is expected to reach an average price of $94.77 in 2025, with a high prediction of $187.67 and a low estimate of $1.8639. This indicates an +1,109% rise from the last recorded price of $7.84.
Month Average Low High Change from today's price
September, 2025 $168.56 $93.52 $187.67 +2,050%
October, 2025 $91.21 $84.94 $179.97 +1,063%
November, 2025 $106.64 $81.50 $124.82 +1,260%
December, 2025 $79.00 $76.79 $120.21 +907.72%

Novavax Inc Stock (NVAX) Price Forecast for 2026

The predicted value for Novavax Inc (NVAX) in 2026 is set at an average of $202.45. Estimates vary from a peak of $330.00 to a trough of $74.89, indicating an +2,482% surge from the present price of $7.84.
Month Average Low High Change from today's price
January, 2026 $123.99 $74.89 $130.30 +1,482%
February, 2026 $123.11 $104.42 $148.81 +1,470%
March, 2026 $125.75 $105.39 $135.89 +1,504%
April, 2026 $276.21 $119.58 $330.00 +3,423%
May, 2026 $226.58 $145.72 $275.48 +2,790%
June, 2026 $178.08 $157.42 $239.81 +2,171%
July, 2026 $130.04 $115.47 $262.02 +1,559%
August, 2026 $208.04 $126.93 $212.86 +2,554%
September, 2026 $186.96 $167.16 $227.86 +2,285%
October, 2026 $188.25 $170.38 $245.02 +2,301%
November, 2026 $236.92 $190.37 $258.37 +2,922%
December, 2026 $205.44 $196.39 $276.18 +2,520%

Novavax Inc Stock (NVAX) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Novavax Inc (NVAX) is $134.13, with a high forecast of $234.91 and a low forecast of $33.35. This indicates an +1,611% increase from the last price of $7.84.
Month Average Low High Change from today's price
January, 2027 $132.98 $119.75 $190.79 +1,596%
February, 2027 $190.74 $128.48 $199.88 +2,333%
March, 2027 $215.73 $136.66 $227.41 +2,652%
April, 2027 $109.24 $99.52 $234.91 +1,293%
May, 2027 $87.76 $64.80 $105.95 +1,019%
June, 2027 $70.16 $67.93 $99.82 +794.84%
July, 2027 $72.09 $64.26 $84.04 +819.55%
August, 2027 $45.10 $44.48 $76.10 +475.25%
September, 2027 $53.75 $39.79 $61.68 +585.57%
October, 2027 $38.71 $33.35 $55.95 +393.70%
November, 2027 $74.59 $37.85 $75.24 +851.45%
December, 2027 $39.95 $36.64 $73.81 +409.60%

Novavax Inc Stock (NVAX) Price Forecast for 2028

In 2028, Novavax Inc (NVAX) is projected to reach an average price of $23.33, with a high projection of $42.50 and a low estimate of $4.1541. This indicates an +197.57% rise from the last price of $7.84.
Month Average Low High Change from today's price
January, 2028 $28.88 $28.81 $42.50 +268.36%
February, 2028 $16.70 $16.35 $31.86 +112.97%
March, 2028 $20.78 $14.50 $23.15 +165.00%
April, 2028 $15.05 $14.83 $24.17 +92.00%
May, 2028 $8.182 $7.8802 $17.07 +4.36%
June, 2028 $10.08 $7.2738 $12.23 +28.56%
July, 2028 $8.4164 $8.0164 $11.18 +7.35%
August, 2028 $5.0655 $4.7955 $8.8183 -35.39%
September, 2028 $7.0127 $4.1541 $7.5027 -10.55%
October, 2028 $6.2699 $5.4499 $8.2363 -20.03%
November, 2028 $6.1889 $5.2053 $9.9217 -21.06%
December, 2028 $6.0061 $5.1361 $7.0975 -23.39%

Novavax Inc Stock (NVAX) Price Forecast for 2029

The 2029 price forecast for Novavax Inc Stock (NVAX) is $5.5239 on average, with a high prediction of $8.8977 and a low estimate of $2.15. This represents an -29.54% decrease from the previous price of $7.84.
Month Average Low High Change from today's price
January, 2029 $7.8651 $5.4779 $8.7597 +0.32%
February, 2029 $6.6423 $5.4337 $8.1923 -15.28%
March, 2029 $6.3095 $5.8995 $8.8977 -19.52%
April, 2029 $5.6567 $5.3253 $6.7549 -27.85%
May, 2029 $4.8557 $4.5657 $6.1057 -38.06%
June, 2029 $4.1929 $3.9193 $5.1275 -46.52%
July, 2029 $3.4302 $3.4302 $4.6747 -56.25%
August, 2029 $2.6392 $2.5892 $3.972 -66.34%
September, 2029 $3.9364 $2.1752 $4.1064 -49.79%
October, 2029 $3.3554 $2.8782 $4.6982 -57.20%
November, 2029 $2.6326 $2.4726 $3.6072 -66.42%
December, 2029 $2.81 $2.15 $5.88 -64.16%

Novavax Inc Stock (NVAX) Price Forecast for 2030

Novavax Inc Stock (NVAX) is expected to reach an average price of $7.107 in 2030, with a high forecast of $14.15 and a low forecast of $0.0683. This signifies an -9.35% decrease from the last price of $7.84.
Month Average Low High Change from today's price
January, 2030 $1.313 $0.9481 $4.1836 -83.25%
February, 2030 $1.3024 $1.1524 $3.4552 -83.39%
March, 2030 $0.6559 $0.3932 $1.216 -91.63%
April, 2030 $2.2613 $0.3589 $4.4877 -71.16%
May, 2030 $1.4393 $1.3593 $4.0021 -81.64%
June, 2030 $0.8237 $0.5437 $1.5129 -89.49%
July, 2030 $0.1317 $0.0683 $1.2345 -98.32%
August, 2030 $0.4242 $0.0953 $2.0389 -94.59%
September, 2030 $0.3556 $0.2777 $1.1406 -95.46%
October, 2030 $4.0786 $0.076 $6.3678 -47.98%
November, 2030 $4.753 $3.7622 $14.15 -39.38%
December, 2030 $11.80 $3.2266 $12.03 +50.48%
$24.65
price up icon 0.94%
$85.04
price down icon 1.72%
$26.20
price up icon 0.73%
$110.88
price up icon 0.10%
$131.88
price down icon 0.54%
biotechnology ONC
$313.67
price down icon 0.10%
Cap:     |  Volume (24h):